Cyclomics
Pre-clinicalDiscover Cyclomics, pioneers in precision cancer diagnostics using breakthrough consensus-sequencing paired with the Nanopore platform. Our innovative solutions enable ultra-sensitive detection of cancer mutations directly from blood samples, transforming the future of liquid biopsy. Learn more about how Cyclomics is revolutionizing early cancer detection, monitoring, and personalized treatment with cutting-edge, accessible molecular diagnostics.
About
Discover Cyclomics, pioneers in precision cancer diagnostics using breakthrough consensus-sequencing paired with the Nanopore platform. Our innovative solutions enable ultra-sensitive detection of cancer mutations directly from blood samples, transforming the future of liquid biopsy. Learn more about how Cyclomics is revolutionizing early cancer detection, monitoring, and personalized treatment with cutting-edge, accessible molecular diagnostics.
Funding History
1Total raised: $4.5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile